All 106 TCAF (T. ROWE PRICE CAPITAL APPRECIATION EQUITY ETF) Holdings
There are 106 TCAF holdings. Top 10 companies weight: 38.18%.
Total Market Cap: $37T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (106 stocks) | +35.60% | 32.12 | 22.48 | 0.41 | +25.47% | +26.96% | 1.32 | ||||||||||
101 | MLTX | Moonlake Immunotherapeutics Class A | 0.05% | $19.05 | $1.42B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +46.98% | $28 | +13.76% | 0.95 |
102 | MAZE | Maze Therapeutics Inc | 0.05% | $28.37 | $1.46B | Biotechnology | Healthcare | N/A | N/A | 8.53 | N/A | N/A | N/A | 77 | +120.48% | $63 | 0.00% | 0.87 |
103 | QNT | Quantinuum Inc Class A | 0.03% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
104 | MBGL | Mobility Global Inc | 0.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
105 | n/a | Contra Arcellx Inc Common Stock | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
106 | n/a | Us Dollar | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
TCAF (T. ROWE PRICE CAPITAL APPRECIATION EQUITY ETF) Sector Allocation
INFORMATION TECHNOLOGY
27.50%HEALTHCARE
17.50%COMMUNICATION SERVICES
11.20%CONSUMER DISCRETIONARY
9.30%FINANCIALS
8.90%UTILITIES
8.80%INDUSTRIALS
5.80%CONSUMER STAPLES
3.70%ENERGY
0.50%MATERIALS
0.00%REAL ESTATE
0.00%